As of Dec 09
| +0.07 / +6.14%|
The 5 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 2.00, with a high estimate of 3.00 and a low estimate of 1.50. The median estimate represents a +65.29% increase from the last price of 1.21.
The current consensus among 5 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.